It would require integrated data, AI-ready data pipelines and committed sponsors who can carry use cases into clinical ...
The agreement gives Servier’s researchers access to Owkin’s K Pro platform and multimodal patient data to study hard-to-treat cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results